Search research articles
Contact Us
Filters
Showing results (121-130 of 182) with videos related to
Page
of 19
Sort By:
The Journal of Investigative Dermatology
|
September 21, 2017
Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3
Katia Boniface, Clément Jacquemin, Anne-Sophie Darrigade, et al.
Trials
|
July 23, 2022
Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice
Nanja van Geel, Iltefat H Hamzavi, Amit G Pandya, et al.
Science Translational Medicine
|
September 3, 2010
Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus
Pierre Duffau, Julien Seneschal, Carole Nicco, et al.
The New England Journal of Medicine
|
October 19, 2022
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
David Rosmarin, Thierry Passeron, Amit G Pandya, et al.
American Journal of Clinical Dermatology
|
March 14, 2025
Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 Years
Raj Chovatiya, Simone Ribero, Andreas Wollenberg, et al.
The New England Journal of Medicine
|
March 15, 2023
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
Jonathan I Silverberg, Emma Guttman-Yassky, Diamant Thaçi, et al.
JAMA Dermatology
|
November 10, 2021
Evaluation of Thalidomide Treatment of Patients With Chronic Erythema Multiforme: A Multicenter Retrospective Cohort Study
Camille Roux, Emilie Sbidian, Jean-David Bouaziz, et al.
Therapeutic Advances in Chronic Disease
|
November 10, 2025
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication
David Rosmarin, Thierry Passeron, Amit G Pandya, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 21, 2023
Clinician-reported outcome measures for the assessment of vitiligo: A scoping review
Nanja van Geel, Jolien Duponselle, Liesbeth Delbaere, et al.
JCI Insight
|
May 6, 2020
Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo
Nesrine Boukhedouni, Christina Martins, Anne-Sophie Darrigade, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 182) with videos related to
Sort By:
Page
of 19
The Journal of Investigative Dermatology
|
September 21, 2017
Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3
Katia Boniface, Clément Jacquemin, Anne-Sophie Darrigade, et al.
Trials
|
July 23, 2022
Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice
Nanja van Geel, Iltefat H Hamzavi, Amit G Pandya, et al.
Science Translational Medicine
|
September 3, 2010
Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus
Pierre Duffau, Julien Seneschal, Carole Nicco, et al.
The New England Journal of Medicine
|
October 19, 2022
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
David Rosmarin, Thierry Passeron, Amit G Pandya, et al.
American Journal of Clinical Dermatology
|
March 14, 2025
Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 Years
Raj Chovatiya, Simone Ribero, Andreas Wollenberg, et al.
The New England Journal of Medicine
|
March 15, 2023
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
Jonathan I Silverberg, Emma Guttman-Yassky, Diamant Thaçi, et al.
JAMA Dermatology
|
November 10, 2021
Evaluation of Thalidomide Treatment of Patients With Chronic Erythema Multiforme: A Multicenter Retrospective Cohort Study
Camille Roux, Emilie Sbidian, Jean-David Bouaziz, et al.
Therapeutic Advances in Chronic Disease
|
November 10, 2025
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication
David Rosmarin, Thierry Passeron, Amit G Pandya, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 21, 2023
Clinician-reported outcome measures for the assessment of vitiligo: A scoping review
Nanja van Geel, Jolien Duponselle, Liesbeth Delbaere, et al.
JCI Insight
|
May 6, 2020
Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo
Nesrine Boukhedouni, Christina Martins, Anne-Sophie Darrigade, et al.
Page
of 19